Browse By: Country ι Category ι Latest Reports ι Tag

Gene Therapy Partnering Terms and Agreements

Pages » 526
Published By » Current Partnering
Price » $1995
In stock
View Report Details
Description

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in gene therapypartnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gene therapypartnering contract documents Top gene therapy deals by value   The Gene Therapy Partnering Terms and Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and wh... Click here for more details


Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
GBI Research’s report, “Musculoskeletal Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis, provides in-depth analysis of unmet needs, drivers and barriers t
Published Date: Oct 2010
Price: $3500
Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market
GBI Research’s pharmaceuticals report, “Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis
Published Date: Sep 2010
Price: $3500
Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
GBI Research’s new report, “Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis therapeutics
Published Date: Oct 2010
Price: $3500
Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
GBI Research, the leading business intelligence provider, has released its latest report, “Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics” that provides key data, information and analysis of the major trends and issu
Published Date: Dec 2010
Price: $3500
Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
GBI Research, the leading business intelligence provider, has released its latest report, “Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions” that provides key data, information and analy
Published Date: Dec 2010
Price: $3500
Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market
GBI Research, the leading business intelligence provider, has released its latest research “Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market” which provides insight about contraceptive sales and price for
Published Date: Dec 2010
Price: $3500
Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential
GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential”, which provides insights into oncology sales and price forecasts until 2017
Published Date: Dec 2010
Price: $3500
Seasonal Influenza Vaccine Market in Asia - Pacific Region - Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth
GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific Region-Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth” which essentially provides insights on seasonal influenz
Published Date: Jan 2011
Price: $3500
Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market
GBI Research, the leading business intelligence provider, has released its latest research, Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market, which provides insights into oncology sales and price fore
Published Date: Jan 2011
Price: $3500
Targeted Therapeutics - Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market
GBI Research, the leading business intelligence provider, has released its latest research Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market. The report provides in-depth analysis of the major targeted therapeutics. The Market Drivers and Restraints f
Published Date: Feb 2011
Price: $3500

 


 

Related News

China Denies Encroachment of South China Sea Ahead of ASEAN Meeting
Ahead of the approaching ASEAN meeting, Chinese officials are trying to negate accusations regarding aggression in the South China Sea. In the last couple of months, the Chinese government has received severe criticism for construction projects in the South China Sea. Japan and Philippines, which are some of the regional powers in the region are worried these construction projects reflect a regenerated imperialist outlook in the communist nation. Leaders from other regional powers fear tha
Date: Aug 04

Japan Temporarily Stops Construction of U.S. Base
Japan recently announced that it was temporarily stopping construction of a disputed U.S. air base on Okinawa Island for almost a month to conduct talks between the central government and the island authorities that are opposing the facility. The residents of Okinawa, which is the site of the bloody war between the Japanese and the U.S forces towards the end of the second world war, have long raised objection for presence of tens of thousands of U.S. forces and U.S. military fixtures on 18% o
Date: Aug 04

China doubles its Efforts into the Solar Energy Sector
The trend of countries pledging to cut down their carbon emissions has been growing strong in the West, however, several countries in the East are also showing commitment to reducing their carbon footprint. Furthermore, China known for its substantial carbon footprint has pledged to reduce its carbon emissions by a great degree in the coming few years. This initiative by China has been applauded by several countries around the world such as France. Recent figures show that China has increased
Date: Aug 04

Butterfly Stance Inspiring Solar Panel Designs
Bio mimicry has been used by engineers and scientists around the world to develop many ground breaking designs. Recently, engineers from the University of Exeter are exploring the ways to mimic the stance of the Cabbage White butterfly in their solar panels design. It is expected that these panels inspired from the butterfly stance will boost the efficiency by around 50 per cent. The design inspired by the Cabbage White butterfly is actually a common sight in Europe during the summer days. Ho
Date: Aug 04

Tyson Foods’ Hit by Rising Cost of Beef, Reports 10% Decline in Q3
One of the biggest processors of beef, pork, and chicken, Tyson foods reported on Aug 03, 2015, that the soaring cost of cattle has led to a fall of US$84 million in the business of the company in the Q3 of this fiscal year. The company also stated that if the beef market does not improves very soon, the company is afraid that it will not meet its earnings projection for this full-year. Tyson registered a revenue amounting to US$10.07 billion in Q3, citing an increase of 4% comparing to 2014.
Date: Aug 04

ALEC Defends Deal between Australia and China over Live Cattle Exports
The recent deal of Australia with China over the live cattle exports has been defended by the Australian Livestock Exporters’ Council (ALEC) after the RSPCA criticized the deal on Aug 03, 2015. Australia and China have signed an agreement over the feeder and butchery cattle health protocol in July, which was expected to help in opening up exceptional access for live cattle exports from Australia to China. In a statement the CEO of RSPCA Australia, Mr. Heather Neil stated that exporting
Date: Aug 04

Oil Prices Rise with Gains in China Stock Market
Global prices of crude on Tuesday went up from multi-month lows, backed by a rally in the stock market in China, the second largest oil consumer in the world. However, traders and analysts said that a weak demand outlook and abundant supply are unlikely to hold on to the crude rebound.  Global benchmark for oil Brent as well as U.S. crude settled at a higher level for the first time in four sessions. This was reported a day after the 5 per cent rout triggered on Monday by China’s w
Date: Aug 04

Spending Cuts by Oil Companies Likely in Exploration and Drilling
Some of the largest oil companies in the world have promised to reduce their costs of larger projects amid slipping oil prices. However, with crude priced below US$ 50 per barrel, the unrelenting price weakness indicates that these companies will have to dig much deeper to recover.  Over the past year, prices of oil dropped a massive 60 per cent from a high of US$ 114 per barrel in 2014. Amidst this, energy giant in the United Kingdom BP PLC started experimenting with new projects aimed
Date: Aug 04

Upfront Payout of US$65 Million for Isis Pharma
Isis Pharmaceuticals continues to expand into multiple disease sectors, in which the latest move includes the signing of a top level drug development partnership with another drug company. The new partnership with AstraZeneca will get US$65 million to Carlsbad biotech upfront. The deal also calls for Isis Pharma to discover and work on drugs that are useful in cardiovascular, kidney, and metabolic diseases. They are to develop these drugs using the antisense technology developed by Isis. I
Date: Aug 03

16.59% Rally of China Pharma Holdings’ Shares
China Pharma Holdings, Inc. company shares rose by 16.59% in the previous week. The pharma company still tallied to a loss of 23.53% during the past four weeks. The company share did surpass the S&P 500 in the previous week by 15.25%. However, they have underperformed the index by 24.51% within the last four weeks. China Pharma Holdings, Inc. shares have slowed down by 29.73% within the previous three month period. The current year-on-year performance is -13.36%. The company shares
Date: Aug 03

Upcoming Reports

Global Radiotherapy Market (Products & Applications) - Global Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018
Radiotherapy is a treatment for cancer which uses beams of high energy radiation to kill cancer tissues in the body. This therapy stops cancer cells from multiplying. Also called radiation therapy, radiotherapy is emerging as a major technology for killing the cancer disease. The global radiot
Published By: Transparency
Price: $4795
Cancer Therapeutics And Biotherapeutics Market- Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
Cancer is affecting about more than 10 million people every year globally and this number is expected to increase by 2.4% by the year 2020 and reach to 14 million. Biotherapy is one of the most promising and new approach in treatment of cancer as it enhances the natural tendency of body to defend
Published By: Transparency
Price: $4795
Occult Blood Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
Occult blood testing is carried out to test for the presence of microscopic or invisible blood cells in the stool. It is a type of colorectal cancer screening test. Occult blood is the sign of a problem in the digestive system, which can be a polyp, growth, or a cancer in the rectum or colon. Once
Published By: Transparency
Price: $4595
Nanomedical Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
Factors such as rising prevalence of chronic medical conditions in the fields of neurosciences and cardiology, increasing research and development initiatives in the healthcare sector, and technological advancements in the field of medical sciences are responsible for the growth of this market.
Published By: Transparency
Price: $4595
Testosterone Replacement Therapy (TRT) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
The testosterone replacement therapy is a process of giving testosterone when testes do not produce sufficient amount of testosterone because of injury, damage or absence. The testosterone replacement therapy has gained the momentum in last decade with high penetration in surgery market. The tes
Published By: Transparency
Price: $4795
Uterine Cancer Therapies and Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Uterine cancer is a cancer of uterus and is classified into the following four types, namely uterine sarcomas, endometrial cancer, cervical cancer and gestational trophoblastic disease. These cancers arise from malignancies of connective tissues, endometrium and cervix uteri of the uterus. Uterine
Published By: Transparency
Price: $4795
Nucleic Acid Aptamers (Diagnostics and Therapeutics) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
Nucleic acid aptamers are species of nucleic acid that are engineered in in vitro selection or SELEX i.e. systematic evolution of ligands by exponential enrichment. Aptamers bind different molecular targets such as proteins, nucleic acids, cells, organisms and other molecules and assist in molecul
Published By: Transparency
Price: $4795
Cardiac Resynchronization Therapy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Cardiac resynchronization therapy (CRT) devices are intended to treat heart failure. These devices aid in the proper synchronization of heart beats by sending small undetectable signals to lower chambers of the heart. This in turn enables the heart to pump blood and oxygen more efficiently. This i
Published By: Transparency
Price: $4795
Rheumatology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
With increasing joint and connective tissue problems caused by hectic lifestyles, non-nutritious food habits, and lack of physical workouts, the demand for rheumatology is on an increase on a global scale. Rheumatology is concerned with the therapy of rheumatic diseases and problems involving join
Published By: Transparency
Price: $4795
Compression Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Compression therapy is a process of applying external pressure to treat various chronic wounds such as deep venous thrombosis, phlebitis and lymphedema. A common myth prevailing among people is that compression bandages and clothes hinder the blood circulation but in reality these products are desig
Published By: Transparency
Price: $4795